Characterization of JAK1 and JAK2 Activation in Gingival Tissues During Homeostasis and Periodontitis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Chile

About this trial

The goal of this observational study is to examine JAK1/2 pathway activation in gingival tissues from adults with healthy gingiva and those with inflamed gingiva (periodontitis). The main question it aims to answer is:

Is the JAK1/2 pathway overactivated in periodontitis compared to health?

Participants with healthy gingiva and periodontitis will donate gingival tissue to study the JAK1/2 pathway. All participants wil receive diagnosis and treatment of the gingival condition.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults

Sistemically healthy

Disqualifiers

Active Maliganancy

History of radiation to the head-neck region

Chemotherapy or radiation within the last 5 years

History of hepatitis B/C or HIV infection

Trial population

Adults from the northern area of Santiago, Chile

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

30 Participants
are grouped into 2 trial groups
Group A: Healthy gingiva
Group B: Periodontits

Trial outcomes

Primary outcomes

1

JAK1/2 pathway activation in gingival tissues

The activation of the JAK1/2 pathway will be evaluated by the phophorilation of JAK1/2 in the gingival tissues determined by western blot. Patients will be categorizied as 0, 1, 2. 0 = no phosphorilation 1. = mild phosphorilation 2. = intense phosphorilation

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.